Drug
Amjevita NDC Codes
Amjevita is listed in the FDA NDC Directory as 18 finished products from 3 labelers.
Overview
Active ingredient: Adalimumab. Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Generic name
- Adalimumab-atto
- Active ingredients
- Adalimumab
- Labelers
- Amgen, Inc, Amgen USA Inc., Nuvaila Limited
- Strengths
- Adalimumab 40 mg/.4mL; Adalimumab 80 mg/.8mL; Adalimumab 20 mg/.2mL; Adalimumab 40 mg/.8mL; Adalimumab 10 mg/.2mL; Adalimumab 20 mg/.4mL
- Dosage forms
- Injection
- Routes
- Subcutaneous
- Drug classes (FDA established)
- Tumor Necrosis Factor Blocker
- HCPCS / J-code
- J0135 — Injection, adalimumab, 20 mg
- Package NDCs
- 30
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.2mL | InjectionSubcutaneous | Nuvaila Limited | 84612-399 | 84612-0399-01 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Nuvaila Limited | 84612-479 | 84612-0479-0184612-0479-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | Nuvaila Limited | 84612-481 | 84612-0481-0184612-0481-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Nuvaila Limited | 84612-482 | 84612-0482-0184612-0482-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.2mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-399 | 72511-0399-01 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-479 | 72511-0479-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.2mL | InjectionSubcutaneous | Amgen, Inc | 55513-399 | 55513-0399-01 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Amgen, Inc | 55513-479 | 55513-0479-0155513-0479-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | Amgen, Inc | 55513-480 | 55513-0480-0155513-0480-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | Amgen, Inc | 55513-481 | 55513-0481-0155513-0481-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Amgen, Inc | 55513-482 | 55513-0482-0155513-0482-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 80 mg/.8mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-481 | 72511-0481-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.4mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-482 | 72511-0482-0172511-0482-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 10 mg/.2mL | InjectionSubcutaneous | Amgen, Inc | 55513-413 | 55513-0413-01 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.8mL | InjectionSubcutaneous | Amgen, Inc | 55513-400 | 55513-0400-0155513-0400-0255513-0400-91 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.8mL | InjectionSubcutaneous | Amgen, Inc | 55513-410 | 55513-0410-0155513-0410-02 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 20 mg/.4mL | InjectionSubcutaneous | Amgen, Inc | 55513-411 | 55513-0411-01 | J0135 |
| Amjevitaadalimumab-atto | Adalimumab 40 mg/.8mL | InjectionSubcutaneous | Amgen USA Inc. | 72511-400 | 72511-0400-0172511-0400-02 | J0135 |
Amjevita: common questions
- What is the NDC for Amjevita?
- Amjevita has 18 product NDCs, one for each strength, dosage form and labeler; each product NDC then has one package NDC per package size. Pick the row for your product above to see its package NDCs.
- Is there a J-code for Amjevita?
- Med-Code's HCPCS directory matches J0135 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.